Abstract
An investigator at the New York‐based Feinstein Institutes for Medical Research contends that a new $3.1 million grant from the National Institutes of Health (NIH) will help expand understanding of the genetics of cognitive function and their connection to major mental illnesses. Findings in this area could ultimately lead to breakthrough treatments for neuropsychiatric disorders such as schizophrenia, major depression, autism spectrum disorders and attention deficit hyperactivity disorder (ADHD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
